| Ytd | -67.71% | |
| 1y | -57.30% |
| Open | 1.05 | Prev Close | 1.07 | Low | 1.05 | High | 1.18 | Mkt Cap | 145.00M |
| Vol | 1.67M | Avg Vol | 1.84M | EPS | -0.97 | P/E | N/A | Forward P/E | -1.36 |
| Beta | 1.60 | Short Ratio | 6.98 | Inst. Own | 61.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.62 | 200-d Avg | 3.62 | 1yr Est | 8.40 |
ADCT News
LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-s
100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamabFull data
100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamab Full data
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately
Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.6
Discover why ADC Therapeutics (NYSE:ADCT) stock is tumbling on Friday as a prominent Wall Street ana
RBC Capital analyst Leonid Timashev downgrades ADC Therapeutics (NYSE:ADCT) from Outperform to Se
ADC Therapeutics stock plunges premarket as LOTIS-3 trial shows elevated serious, Grade 5 adverse ev
Shares of PVH fell 21.42% in pre-market trading even after strong Q1. Gainers include CXApp, TaoWeav
Company to host conference call today at 4:30 p.m. EDTLAUSANNE, Switzerland, June 3, 2026 /PRNewswir